NYMOX PHARMACEUTICAL CORP's ticker is NYMX and the CUSIP is P73398102. A total of 46 filers reported holding NYMOX PHARMACEUTICAL CORP in Q2 2017. The put-call ratio across all filers is 4.51 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2021 | $10,000 | -28.6% | 5,046 | -43.3% | 0.00% | – |
| Q2 2021 | $14,000 | -82.3% | 8,907 | -74.8% | 0.00% | – |
| Q1 2021 | $79,000 | +132.4% | 35,358 | +159.0% | 0.00% | – |
| Q4 2020 | $34,000 | -27.7% | 13,652 | -27.9% | 0.00% | – |
| Q3 2020 | $47,000 | -39.0% | 18,930 | -12.2% | 0.00% | – |
| Q2 2020 | $77,000 | – | 21,569 | +2156800.0% | 0.00% | – |
| Q2 2019 | $0 | -100.0% | 1 | -100.0% | 0.00% | – |
| Q1 2019 | $18,000 | – | 9,261 | +1755.9% | 0.00% | – |
| Q4 2018 | $0 | -100.0% | 499 | -95.9% | 0.00% | – |
| Q3 2018 | $30,000 | +275.0% | 12,300 | +418.8% | 0.00% | – |
| Q2 2018 | $8,000 | -71.4% | 2,371 | -65.5% | 0.00% | – |
| Q1 2018 | $28,000 | +47.4% | 6,879 | +24.0% | 0.00% | – |
| Q4 2017 | $19,000 | +533.3% | 5,547 | +686.8% | 0.00% | – |
| Q3 2017 | $3,000 | -83.3% | 705 | -83.3% | 0.00% | – |
| Q2 2017 | $18,000 | – | 4,222 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| MARATHON CAPITAL MANAGEMENT | 55,000 | $179,000 | 0.09% |
| WEDBUSH SECURITIES INC | 180,945 | $590,000 | 0.09% |
| Brown Advisory Securities, LLC | 28,000 | $91,000 | 0.03% |
| FNY Managed Accounts LLC | 8,000 | $26,080,000 | 0.02% |
| FT Options LLC | 10,000 | $26,000 | 0.02% |
| WEBSTER BANK, N. A. | 40,000 | $130,000 | 0.02% |
| GSA CAPITAL PARTNERS LLP | 30,907 | $101,000 | 0.01% |
| GOFEN & GLOSSBERG LLC /IL/ | 25,000 | $82,000 | 0.00% |
| NATIONAL PLANNING CORP | 11,000 | $32,000 | 0.00% |
| Virtu KCG Holdings LLC | 24,705 | $81,000 | 0.00% |